We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Excellus Holdings, San Diego, Calif., has drawn an FDA Form 483 for inspectional observations that include senior management passing the buck on customer complaints. Read More
Medcura’s injectable biopolymer LifeFoam significantly extended survival time in an animal study, researchers reported in the journal Surgery. Read More
Philips has agreed to pay more than $24 million to resolve False Claims Act allegations that it misled federal health care programs by paying kickbacks to durable medical equipment (DME) suppliers, said the Department of Justice (DOJ) in a statement. Read More
Alexandria, Va.-based Spok received a Form 483 after an April inspection by the FDA found incomplete corrective and preventive action (CAPA) procedures and design control lapses. Read More